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Background: Leishmania possess a unique trypanothione-
dependent redox metabolism with pivotal role in protection from
oxidative damage and drug resistance. The cascade of trypanoth-
ione biosynthesis depends on L-cysteine as the precursor, whereas,
cysteine bioavailability is itself dependent on the cysteine biosyn-
thesis pathway which includes enzyme cysteine synthase (CS).
However, despite the apparent dependency of redox metabolism
on cysteine biosynthesis pathway, the role of CS in drug resistance
and redox homeostasis has remained unexplored. Herein, we have
attempted to investigate the role of LdCS in Amphotericin B (Amp
B) sensitive vs. resistant isolates of L. donovani.
Methods & Materials: LdCS was cloned in pXG-GFP+ vector to
express LdCS as fusion proteins with a C-terminal GFP tag. The
construct LdCS-GFP was transfected by electroporation in the L.
donovani sensitive strainpromastigotes and transformants selected
upto ﬁnal concentration of 200 g/ml G418. MTT assay was per-
formed to determine IC50 value of LdCS-GFP overexpressor and
Amp B sensitive strains of L. donovani under different ROS induc-
ers such as, H2O2, menadione and SNAP. Further, ROS levels, thiol
content and enzymatic activities of LdCS, peroxidase and SODwere
analyzed.
Results: Our results demonstrate stage-speciﬁc increase of LdCS
expression and its enzymatic activity, accompanied by a higher
thiol content, which implies that LdCS is upregulated in Amp B
resistant isolates and during stationary stages of growth to meet
the increased thiol demand of respective stages/isolates culmi-
nating into enhanced stress tolerance. In fact, overexpression of
LdCS-GFP in sensitive strains imparted enhanced oxidative stress
tolerance to the over-expressing parasites as compared to the wild
type (WT) parasites. The IC50 values of LdCS-GFP toward H2O2,
menadione and SNAP was found to be 217±8.7M, 16.5±2.5M
and 370±9.7M, respectively, which was ∼1.87, ∼2.21 and ∼1.34
fold higher than WT parasites. Furthermore, enzymatic assays,
thiol content and immunoblot analysis showed that these oxidants
induced LdCS-GFP, as well as endogenous CS and thiol cascade
proteins expression in L. donovani suggesting a ROS regulated
mechanism of LdCS expression and thiol pathway proteins.
Conclusion: The LdCS expression is modulated by ROS proba-
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Background: Visceral Leishmaniasis (VL) is a major public
health problem in the Indian subcontinent.Mononuclear cells have
direct role in initiation of inﬂammation, anti parasitic defences and
ultimately in maintenance of tissue homeostasis. Monocytes play
an important role as immune effector cells but their role in VL is not
well known.Wehypothesised thatM2macrophagesplay an impor-
tant role in VL pathogenesis and aimed to characterise monocytes
phenotypically and functionally.
Methods & Materials: We established M1 and M2 macrophage
polarization dynamics in the whole blood of active VL patients
at an intervals of 7 days for four weeks until their drug treat-
mentwas complete.Monocyteswere phenotypically charecterised
by immunophenotyping studies for chemokine receptors CCR2,
CX3CR1, CCR7 and cell adhesion molecules VCAM1, ICAM1,
PECAM1. Functional charecterization includes quantitation of
intracellular TNF-, IL-6, IL-1 production, gene expression level
measurement of various M1, M2 markers in CD14 enriched cells
from active and cured VL cases and in endemic healthy controls.
Myeloperoxidase expression, phagocytosis and intracellular Leish-
mania parasite killing by monocytes were also examined.
Results: We found only minor changes in the frequency of
M1 and M2 macrophages at the beginning and end of drug treat-
ment, but observed several signiﬁcant changes in the expression
of cell surface markers (CD206, CD163) used to identify these cell
subsets. In particular, we found that M2 macrophages increased
in frequency and changed expression of cell surface molecules
14 days after drug treatment commenced, suggesting a potential
role in tissue repair and homeostasis. We also observed signiﬁ-
cantly upregulated expression of several M2 markers (TGM2, PKM,
SLC2A1) at gene level. We found reduced expression of CD14 on
monocytes fromactiveVLpatients, but exacerbatedTNF-, IL-6 and
dercreased production of IL-1 in response to SLA/LPS stimulation,
comparedwith the samecells fromdrug cured andendemic control
samples. We also found decreased myeloperoxidase expression by
monocytes in VL.
